Old Web
English
Sign In
Acemap
>
authorDetail
>
Jouhara Chouitar
Jouhara Chouitar
Millennium Pharmaceuticals
Melanoma
Raf Kinase Inhibitor
Pharmacodynamics
Pharmacology
Pharmacokinetics
3
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
493 Preclinical pharmacokinetic (PK)/pharmacodynamic (PD)/Efficacy modeling for MLN2480, an investigational pan-RAF kinase inhibitor, in A375 and SKMEL-2 human melanoma xenografts
2014
European Journal of Cancer
M. Patel
Jouhara Chouitar
Jerome Mettetal
Esha Gangolli
Suresh K. Balani
P. Shimoga
Katherine M. Galvin
Wen Chyi Shyu
Arijit Chakravarty
C.J. Zopf
Show All
Source
Cite
Save
Citations (0)
Abstract C146: Combination treatment with the investigational RAF kinase inhibitor MLN2480 and the investigational MEK kinase inhibitor TAK-733 inhibits the growth of BRAF mutant and RAS mutant preclinical models of melanoma and CRC.
2013
Molecular Cancer Therapeutics
Elizabeth Grace Carideo Cunniff
Julie Zhang
Jouhara Chouitar
Jerome Mettetal
Kazuhide Nakamura
Takeo Arita
Akito Nakamura
Masanori Okaniwa
Tomoyasu Ishikawa
Sei Yoshida
Robyn Fabrey
Patrick Vincent
Kurt Eng
Khristofer Garcia
Deanna Borelli
Teena Vagrhese
Steve Stroud
Saurabh Menon
Mike Kuranda
Katherine M. Galvin
Show All
Source
Cite
Save
Citations (3)
Abstract A215: Integrated analysis of clinical pharmacokinetics (PK), nonclinical PK/efficacy (E) and pharmacodynamic (PD)/E relationships, and translational PK/PD simulations to guide clinical dose and schedule of MLN2480, an oral investigational pan-RAF kinase inhibitor.
2013
Molecular Cancer Therapeutics
Stephanie Faucette
Jerome Mettetal
Xiaofei Zhou
Jouhara Chouitar
Mayank Patel
Michael Bargfrede
Katherine M. Galvin
Viviana Bozon
Karthik Venkatakrishnan
Show All
Source
Cite
Save
Citations (0)
1